BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 5978465)

  • 1. [Clinico-experimental studies on decreasing blood lipids in geriatrics].
    Bracharz H; Laas H
    Med Monatsschr; 1966 Oct; 20(10):471-6. PubMed ID: 5978465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polyunsaturated phosphatidyl choline (EPL) in the treatment of cerebral arteriosclerosis and arteriosclerosis of the lower extremities].
    Ciammaichella A; Solitro A; Arcuri P
    Clin Ter; 1975 Jul; 74(1):55-62. PubMed ID: 1222517
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of drugs affecting lipids on atherosclerosis.
    Ditschuneit H
    Horm Metab Res; 1974; Suppl 4():191-4. PubMed ID: 4421312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drugs which decrease serum lipids].
    Oye I
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):32-3. PubMed ID: 4691222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S
    Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
    [No Abstract]   [Full Text] [Related]  

  • 7. Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
    Likoff W
    Geriatrics; 1972 May; 27(5):91-8. PubMed ID: 5022811
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications for surgical treatment and medical treatment of atherosclerosis].
    Paredero Del Bosque Martin V
    Minerva Med; 1980 Oct; 71(40):2963-7. PubMed ID: 7454082
    [No Abstract]   [Full Text] [Related]  

  • 9. [Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
    Zeller W; Christ F
    Med Klin; 1966 Jan; 61(4):136-9. PubMed ID: 5983158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cosaldon in the treatment of cerebral arteriosclerosis].
    Dzialek E; Orzechowska-Wolczyk M; Zawadzki Z
    Wiad Lek; 1975 Sep; 28(18):1547-9. PubMed ID: 1163042
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new pharmacological association in therapy of dyslipidemic and arteriosclerotic syndromes].
    Cucinotta D
    Minerva Med; 1972 Feb; 63(15):870-85. PubMed ID: 4259330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
    Warembourg H; Ketelers JY; Ginestet A
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral angiodynamic effects of nicotinic acid in man. (Polygraphic and angiographic studies)].
    Corsi C; Spinelli P
    Rass Neurol Veg; 1967 Dec; 21(6):337-52. PubMed ID: 5608551
    [No Abstract]   [Full Text] [Related]  

  • 14. [Specific range of action of a new gerontotherapeutic agent. Psychopharmacological and therapeutic study].
    Oswald WD; Zeus L
    Med Welt; 1969 Jun; 25():1439-44. PubMed ID: 4978450
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the relation between the mobilization of free fatty acids (FFA) and diabetic acidosis: effects of nicotinic acid].
    Vecchi GP; Salvioli GF; Marani L
    Rev Atheroscler (Paris); 1968; 10(1):20-5. PubMed ID: 4971277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of cerebral sclerosis from the viewpoint of the practitioner].
    Orth H
    Z Allgemeinmed; 1970 May; 46(15):800-5. PubMed ID: 5522943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic correction of senile behavior characteristics with Wallerox. Contribution on experimental psychological geriatrics].
    Oswald WD; Müller-Egloff P; Becker E; Wilde M
    Munch Med Wochenschr; 1969 Jun; 111(26):1444-8. PubMed ID: 4980146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hypercholesterinemia with beta-pyridylcarbinol. II. Side effects and disscussion].
    Zöllner N; Gudenzi M
    Med Klin; 1966 Dec; 61(51):2036-40. PubMed ID: 5996572
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of lipolytic drugs.
    Geill T
    Gerontol Clin (Basel); 1965; 7(6):321-9. PubMed ID: 5871676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.